Myeloproliferative Neoplasms (MPN)

Dr. Barry Skikne is certified by the American Board of Internal Medicine with a subcertification in hematology. He completed a fellowship at the University of Kansas Medical Center. He earned his medical degree from the University of Witwatersrand and completed his residency at Johannesburg Hospital.

Dr. Malcovati is an Associate Professor of Hematology at the University of Pavia Medical School and with special interest and expertise in myeloid neoplasms, in particular, myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms. Dr. Malcovati's research group has made a significant contribution to understanding the molecular basis of myeloid neoplasms and to the integration of somatic mutations in the clinical management of patients.

M. Veronica Dioverti, M.D. is a Clinical Associate in the Division of Infectious Diseases at Johns Hopkins University School of Medicine. She graduated from Universidad Nacional de Asuncion and completed her internship and residency training at Bridgeport Hospital-Yale University in Bridgeport, CT. She then pursued General and Transplant/Oncology Infectious Diseases fellowships at Mayo Clinic in Rochester, MN. Her primary clinical interest is caring for transplant, hematology/oncology malignancies and other immunocompromised patients. Her research has focused on optimizing the diagnosis of

Dr. Mojtaba Akhtari is a Hematologist/Oncologist with medical and hematology/oncology training and experience in the United Kingdom and United States of America. He is board certified in Internal Medicine, Hematology and Medical Oncology. Currently he is working at Loma Linda Cancer Center and University Hospital. He is the Chief of Adult Hematopietic Stem Cell Transplant. He was also a member of adult bone marrow transplantation team at UNMC in Omaha, NE, and USC in Los Angeles, CA. His interests include malignant hematological disorders, particularly acute and chronic leukemias as well as